Target intelligence / Profile preview

B-cell receptor-associated protein 31 (BAP31)

Target
BAP31
Molecular classification
Chaperone, Endoplasmic reticulum membrane protein, Other
01

Overview

B-cell receptor-associated protein 31 (BAP31, also known as BCAP31) is a ubiquitously expressed, multi-pass transmembrane protein predominantly located in the membrane of the endoplasmic reticulum (ER)[1][2][3]. Functioning both as a broad-specificity membrane protein chaperone and a quality control factor, BAP31 plays crucial roles in exporting properly folded membrane proteins from the ER to the Golgi, identifying abnormally folded proteins for ER-associated degradation, and acting as a tether and regulatory hub at mitochondria-associated membranes (MAMs)[1][2][3]. It regulates various cellular processes including autophagy, apoptosis (mediating both anti-apoptotic and pro-apoptotic functions depending on its cleavage state), ER and mitochondrial homeostasis, and immune response[1][2][3]. Loss-of-function mutations in BAP31 are linked to severe X-linked neurological disorders such as deafness, dystonia, and central hypomyelination syndrome (DDCH) as well as broader roles in cancer, metabolic disease, and viral pathogenesis[1][2][3].

Other names
BCAP31DXS1357ECDM9
02

Biological functions

Protein quality control (chaperone and cargo receptor for export from ER)Endoplasmic reticulum-associated degradation (ERAD)Apoptosis regulation (via caspase 8 and BCL2)Regulation of autophagyRegulation of cell proliferation and migrationImmune system modulationMaintenance of ER and mitochondrial homeostasis
03

Disease associations

CancerDeafness, dystonia, and central hypomyelination syndrome (DDCH)Involvement in X-linked intellectual disabilityNeurodegenerative disease (Alzheimer’s—regulation of amyloid-β)Metabolic disorders (hepatic lipid metabolism, insulin resistance)Viral pathogenesisOther
04

Safety considerations

Mutations cause severe congenital neurological syndromes (DDCH, X-linked intellectual disability, etc.)[1][2][3].BAP31 manipulates apoptosis and ER-mitochondrial communication, so its modulation could have broad effects on cell viability and homeostasis[1][3].

Beyond the preview

Go deeper on B-cell receptor-associated protein 31 (BAP31).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on B-cell receptor-associated protein 31 (BAP31).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call